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A feature of the cell cycle is that the events of one cycle must be reset before 
the next one begins. New work shows that the replication machinery is 
removed from fully replicated DNA by a conserved ubiquitin- and Cdc48 (p97)- 
dependent pathway. This explains how eukaryotic chromosomes are returned 
to the unreplicated state. 
All organisms must make a perfect copy of the genome during every cell division. For 
eukaryotes this involves separating the steps of DNA replication into distinct cell 
cycle phases. Although great strides have been made in understanding how DNA 
replication is initiated we understand very little about what happens when two 
replication forks converge to terminate this process. Clarifying the final steps of 
replication is important to appreciate how DNA is fully replicated and segregated in a 
timely manner. Recent work now identifies an evolutionarily conserved pathway 
involving the E3 ubiquitin ligase complex CRL2Lrr1 that is required for the removal of 
the replication apparatus when DNA synthesis is complete1, 2. These studies begin to 
explain how DNA replication is irreversibly reset before the next division. 
The tight control of DNA replication within the eukaryotic cell cycle centres on the 
state of the six-subunit replicative helicase Mcm2-7 (Figure 1). For the first step in 
genome duplication, the DNA must be ‘licensed’ to replicate through the loading of 
Mcm2-7 onto double stranded (ds) DNA as an inactive head-to-head double 
hexamer (Figure 1a). This licensing reaction is restricted to late mitosis / early G1 
phase, due to the inhibition of this process by multiple mechanisms in other phases 
of the cell cycle 3.  
Activation of Mcm2-7 double hexamers only occurs following the G1-S transition due 
to the accumulation of Cyclin-dependent kinase (CDK) and Dbf4-dependent kinase 
(DDK) activities. These two kinases cause major structural changes in the Mcm2-7 
double hexamers, resulting in separation of the two hexamers, DNA melting and 
strand passage and recruitment of the helicase cofactors Cdc45 and GINS, to form 
the CMG complex (Cdc45, Mcm2-7, GINS) 4. The exact mechanism by which DDK 
and CDK induce all of these changes in the helicase are not fully understood but the 
outcome is that the active form of the replicative helicase is the CMG complex 
encircling the single leading strand template (Figure 1b). 
The separation of licensing and helicase activation into distinct phases of the cell 
cycle (Figure 1a and b) ensures that DNA cannot be re-replicated within a single cell 
cycle, but how are CMG complexes removed when DNA synthesis is complete to 
reset the cycle? Experiments in Xenopus laevis egg extracts 5 and in budding yeast 6 
have shown that at the end of S-phase the CMG complex is actively removed from 
chromatin. This pathway involves ubiquitylation of the helicase subunit Mcm7, in 
yeast by the ubiquitin ligase SCFDia2 6. The polyubiquitylated CMG complex becomes 
a substrate for the segregase Cdc48 (also called p97 or VCP) 5, 6.  Cdc48 is an 
ATPase that can remodel and potentially unfold ubiquitylated and sumoylated 
substrates 7, although exactly how Cdc48 removes CMG from chromatin is not yet 
known.  
A key question arising from these studies is how this CMG removal pathway is 
specific for terminated complexes. Premature unloading of licensed (Figure 1a) or 
actively replicating (Figure 1b) Mcm2-7 complexes could be lethal. Furthermore, as 
the yeast Mcm7 ubiquitin ligase subunit Dia2 is not conserved beyond fungi, how is 
this pathway regulated in metazoans? Recent studies, using the power of reverse 
genetics in C.elegans and the complete replication of DNA in vitro in Xenopus egg 
extracts 1, 2, 8 shed light on the final events of DNA synthesis in metazoa, completing 
the cycle of Mcm2-7 helicase activation and deactivation (Figure 1). 
A major bottleneck in studying the termination of DNA replication in eukaryotes is 
that termination events happen asynchronously. Elegant work in Xenopus egg 
extracts has solved this problem using a system that can conditionally arrest the 
replication of a plasmid just before termination 8. Relief of this arrest allows the 
synchronous convergence and termination of replication forks. This in vitro system 
was used to demonstrate that when two forks converge, the CMG complex 
transitions from unreplicated ssDNA onto the newly synthesised dsDNA 8 (Figure 1c). 
To understand what happens to this CMG complex at termination the authors 
performed a proteomic analysis of factors associated with chromatin during 
termination. This revealed that an E3 ubiquitin ligase complex CRL2Lrr1 and 
Cdc48/p97 (together with cofactors including Npl4 and Ufd1) are recruited to 
chromatin, causing Mcm7 ubiquitylation and CMG disassembly specifically after 
termination of DNA replication 1. Similar results were achieved through the analysis 
of the replication of sperm chromatin in Xenopus egg extracts 2. Significantly, 
unloading the CMG complex is sufficient to trigger the unloading of other replication 
factors still bound to the helicase, such as DNA polymerases, suggesting that it is the 
topological linkage between CMG and DNA that is key for the stability of the 
replisome on chromatin 1. 
To study metazoan CMG unloading in vivo, Sonneville et al analysed the chromatin 
binding of GFP-tagged CMG components in C. elegans embryos by live microscopy 
2. Using RNAi against all Cdc48 adaptors and Cullin-dependent E3 ligases, they 
showed that Mcm7 ubiquitylation and CMG unloading is caused specifically by the 
C.elegans orthologues of CRL2Lrr1 (CUL-2LRR-1 in C.elegans) and Cdc48/Npl4/Ufd1. 
Importantly knock-down of components of the CMG complex can rescue the sterility 
phenotype of both LRR-1 and CUL-2 mutants in C.elegans 9, suggesting that 
unloading of the CMG complex is an important function of CUL-2LRR-1. Together 
these studies, from yeast to nematodes to vertebrates 1, 2, 5, 6, demonstrate a striking 
evolutionary conservation of an Mcm7 polyubiquitination and Cdc48/p97-dependent 
CMG unloading pathway at termination (Figure 1).  
Whereas down-regulation of Cdc48/Npl4/Ufd1 is sufficient to prevent CMG unloading 
throughout prophase during early embryonic cycles in C.elegans, CRL2Lrr1 down-
regulation did not prevent CMG unloading in late prophase, suggesting the existence 
of other CMG removal pathways in vivo 2. Through further targeted RNAi screening, 
Sonneville et al showed that the Cdc48 partner protein UBXN-3 is required for the 
late prophase removal of CMG from chromatin (Figure 2). This is consistent with 
previous observations that depletion of UBXN-3 in C. elegans causes Cdc45 and 
GINS accumulation on chromatin 10. Interestingly, depletion of UBXN-3 alone has a 
minor effect on CMG persistence, suggesting that CRL2Lrr1 is the primary mechanism 
for CMG removal in vivo 2. As the UBXN-3 pathway is Cdc48-dependent, but 
CRL2Lrr1 independent it is possible that Mcm7 ubiquitylation is not required for this 
pathway (Figure 2). Intriguingly, inhibition of the SUMO protease ULP-4 mimics the 
phenotypes of UBXN-3 downregulation 2, although more work needs to be done to 
understand this pathway in mechanistic detail (Figure 2).  
By studying CMG unloading pathways in vivo, Sonneville et al were able to address 
the physiological importance of this process. For this they combined RNAi of both 
CMG removal pathways, CRL2Lrr1 together with either UBXN-3 or ULP-4. These 
assays showed that these two pathways are synthetically lethal in C. elegans 2, 
which suggests that both pathways for CMG removal are critical in vivo (Figure 2). 
An important area of future study will be to understand why failing to remove the 
CMG complex is lethal. One possibility is that CMG persistence results in re-
replication, which would have significant consequences for the onset of genomic 
instability. Indeed depletion of Faf1 (the human orthologue of UBXN-3) leads to 
replication stress in human cells 10 and multiple mutations in Faf1 have been found 
associated with a wide variety of cancers 11. Whether these effects of loss of Faf1 are 
linked to defects in CMG unloading are not known. 
A key outcome of the in vitro studies 1, 2, 5 together with work in budding yeast 6 is that 
this ubiquitination and Cdc48/p97-dependent removal of Mcm2-7 from chromatin is 
specific for CMG complexes post-termination (Figure 1). This pathway does not 
remove double hexamers in G1 phase or stalled/active CMG complexes before 
termination. The specificity of this pathway for terminated CMG complexes is critical 
to ensure that DNA replication is allowed to go to completion before the Mcm2-7 
complexes are removed from DNA. Understanding how this specificity is achieved 
may lie in a structural understanding of the differences between the Mcm2-7 
complexes during the cell cycle 4. 
The post-termination ubiquitin/Cdc48-dependent removal of CMG forms an 
irreversible switch to end the replication cycle (Figure 1), but is there more to Mcm2-
7 helicase regulation? It is possible that given the importance of the strict control of 
the helicase complex throughout the cell cycle (Figure 1) there will be multiple 
pathways that regulate Mcm2-7 unloading in different contexts. For example, it has 
been shown that Mcm2-7 double hexamers are removed from origins in cells that 
enter quiescence 12 and it is not known what happens to double hexamers that are 
not activated during S-phase. These studies have closed the Mcm2-7 ring cycle, but 
opened a new aspect of eukaryotic replication control. 
Figure legends 
Figure1.  The MCM helicase cycle within the cell cycle. In late mitosis/early G1 phase 
DNA is ‘licensed’ to replicate through the loading of the Mcm2-7 helicase onto double 
stranded (ds) DNA as an inactive double hexamer (a). In S-phase, inactive double 
hexamers are activated to form the CMG complex encircling single stranded (ss) 
DNA (b). At termination, the CMG complex transitions onto replicated dsDNA (c). 
Only the terminated CMG complex is a substrate for the E3 ubiquitin ligase CRL2Lrr1 
(pink arrows). Ubiquitylated CMG complex is a substrate for Cdc48 (together with 
cofactors Ufd1 and Npl4), which removes CMG from DNA, returning chromosomes 
to their unlicensed state, ready for a new cell cycle. 
Figure 2.  At least two pathways target terminated CMG complexes in C.elegans. 
The primary pathway for the removal of CMG complexes in C.elegans is CRL2Lrr1-
dependent, as in Xenopus, but a second pathway functions in late prophase if 
CRL2Lrr1 is inhibited. This back-up CMG removal pathway is UBXN-3-dependent, but 
the mechanism of action of this pathway is not clear. 
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